Sana Biotechnology SANA Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $28.72M-17.8% | $34.92M+16.0% | $30.11M+1.2% | $29.76M-20.0% | $37.19M-17.6% | ||
| $11.46M-5.9% | $12.19M+18.5% | $10.29M-0.5% | $10.34M-10.0% | $11.48M-33.5% | ||
| $48.61M-20.6% | $61.2M+40.6% | $43.52M-54.2% | $94.98M+87.6% | $50.63M-0.5% | ||
| -$48.61M+20.6% | -$61.2M-40.6% | -$43.52M+54.2% | -$94.98M-87.6% | -$50.63M+0.5% | ||
| $951K-25.5% | $1.28M+27.2% | $1M+73.8% | $577K-41.8% | $992K-40.1% | ||
| $453K-58.7% | $1.1M+205% | $360K-39.8% | $598K+140% | $249K— | ||
| -$47.21M+19.7% | -$58.83M-39.6% | -$42.15M+55.1% | -$93.8M-89.9% | -$49.39M-0.7% | ||
| -$0.17+19.0% | -$0.21-31.2% | -$0.16+59.0% | -$0.39-85.7% | -$0.210.0% | ||
| -$46.22M— | —— | -$40.32M+56.2% | -$92.08M-96.0% | -$46.98M— | ||
| -$48.61M+20.6% | -$61.2M-40.6% | -$43.52M+54.2% | -$94.98M-87.6% | -$50.63M+0.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Sana Biotechnology profitable?
- Sana Biotechnology is not currently profitable: it reported a net loss of $242.0M over the trailing twelve months.
- What is Sana Biotechnology's earnings per share?
- Sana Biotechnology's diluted EPS over the trailing twelve months is $-0.93.
- Where does Sana Biotechnology's income statement data come from?
- Every line is extracted from Sana Biotechnology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.